Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication.
Nat Med. 2022 Feb;28(2):333-344. doi: 10.1038/s41591-021-01625-x. Epub 2022 Jan 13.
Nat Med. 2022.
PMID: 35027753